|
1
|
Lonser RR, Glenn GM, Walther M, Chew EY,
Libutti SK, Linehan WM and Oldfield EH: Von Hippel-Lindau disease.
Lancet. 361:2059–2067. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Glasker S, Vergauwen E, Koch CA, Kutikov A
and Vortmeyer AO: Von Hippel-Lindau disease: Current challenges and
future propects. Onco Targets Ther. 13:5669–5690. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Braunstein H and Adelman JU: Histochemical
study of the enzymatic activity of human neoplasms. II.
Histogenesis of renal cell carcinoma. Cancer. 19:935–938. 1966.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Holthöfer H, Miettinen A, Paasivuo R,
Lehto VP, Linder E, Alfthan O and Virtanen I: Cellular origin and
differentiation of renal carcinomas. A fluorescence microscopic
study with kidney-specific antibodies, antiintermediate filament
antibodies, and lectins. Lab Invest. 49:317–326. 1983.PubMed/NCBI
|
|
5
|
Wallace AC and Nairn RC: Renal tubular
antigens in kidney tumors. Cancer. 29:977–981. 1972. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gröne HJ, Weber K, Helmchen U and Osborn
M: Villin-a marker of brush border differentiation and cellular
origin in human renal cell carcinoma. Am J Pathol. 124:294–302.
1986.PubMed/NCBI
|
|
7
|
Kageyama Y, Sasaki S, Yamamura Y, Oshima H
and Ikawa Y: Water channel protein subtype suggests the origin of
renal cell carcinoma. J Urol. 156:291–295. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Motzer RJ, Bander NH and Nanus DM:
Renal-cell carcinoma. N Engl J Med. 335:865–875. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Aizawa S, Kikuchi Y, Suzuki M and Furusato
M: Renal cell carcinoma of lower nephron origin. Acta Pathol Jpn.
37:567–574. 1987.PubMed/NCBI
|
|
10
|
Cao Y, Karsten U, Zerban H and Bannasch P:
Expression of MUC1, Thomsen-Friedenreich-related antigens, and
cytokeratin 19 in human renal cell carcinomas and tubular clear
cell lesions. Virchows Arch. 436:119–126. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nogueira E, Klimek F, Weber E and Bannasch
P: Collecting duct origin of rat renal clear cell tumors. Virchows
Arch B Cell Pathol Incl Mol Pathol. 57:275–283. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cohen C, McCue PA and Derose PB:
Histogenesis of renal cell carcinoma and renal oncocytoma. An
immunohistochemical study. Cancer. 62:1946–1951. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Droz D, Zachar D, Charbit L, Gogusev J,
Chrétein Y and Iris L: Expression of the human nephron
differentiation molecules in renal cell carcinomas. Am J Pathol.
137:895–905. 1990.PubMed/NCBI
|
|
14
|
Markovic-Lipkovski J, Brasanac D,
Todorovic V, Müller CA and Müller GA: Immunomorphological
characteristics of renal cell carcinoma. Histol Histopathol.
10:651–659. 1995.PubMed/NCBI
|
|
15
|
Mandriota SJ, Turner KJ, Davies DR, Murray
PG, Morgan NV, Sowter HM, Wykoff CC, Maher ER, Harris AL, Ratcliffe
PJ and Maxwell PH: HIF activation identifies early lesions in VHL
kidneys: Evidence for site-specific tumor suppressor function in
the nephron. Cancer Cell. 1:459–468. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bobulescu IA, Pop LM, Mani C, Turner K,
Rivera C, Khatoon S, Kairamkonda S, Hannan R and Palle K: Renal
lipid metabolism abnormalities in obesity and clear cell renal cell
carcinoma. Metabolites. 11:6082021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Frew IJ and Moch H: A clearer view of the
molecular complexity of clear cell renal cell carcinoma. Annu Rev
Pathol. 10:263–289. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Turajlic S, Larkin J and Swanton C:
SnapShot: Renal cell carcinoma. Cell. 163:1556. e12015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Büttner F, Winter S, Rausch S, Reustle A,
Kruck S, Junker K, Stenzl A, Agaimy A, Hartmann A, Bedke J, et al:
Survival prediction of clear cell renal cell carcinoma based on
gene expression similarity to the proximal tubule of the nephron.
Eur Urol. 68:1016–1020. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sangoi AR, Karamchandani J, Kim J, Pai RK
and McKenney JK: The use of immunohistochemistry in the diagnosis
of metastatic clear cell renal cell carcinoma: A review of PAX-8,
PAX-2, hKIM-1, RCCma, and CD10. Adv Anat Pathol. 17:377–393. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mubarak M, Al-Gharaibeh N, Sommaruga S, Li
J and Vortmeyer AO: Histological tracking into the third dimension:
Evolution of early tumorigenesis in VHL kidney. J Kidney Cancer
VHL. 8:5–14. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schietke RE, Hackenbeck T, Tran M, Günther
R, Klanke B, Warnecke CL, Knaup KX, Shukla D, Rosenberger C,
Koesters R, et al: Renal tubular HIF-2α expression requires VHL
inactivation and causes fibrosis and cysts. PLoS One. 7:e310342012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Holm-Nielsen P and Pallesen G: Expression
of segment-specific antigens in the human nephron and in renal
epithelial tumors. APMIS Suppl. 4:48–55. 1988.PubMed/NCBI
|
|
24
|
Skinnider BF, Folpe AL, Hennigar RA, Lim
SD, Cohen C, Tamboli P, Young A, de Peralta-Venturina M and Amin
MB: Distribution of cytokeratins and vimentin in adult renal
neoplasms and normal renal tissue: Potential utility of a
cytokeratin antibody panel in the differential diagnosis of renal
tumors. Am J Surg Pathol. 29:747–754. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wilkerson ML, Lin F, Liu H and Cheng L:
The application of immunohistochemical biomarkers in urologic
surgical pathology. Arch Pathol Lab Med. 138:1643–1665. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
van der Horst-Schrivers ANA, Sluiter WJ,
Kruizinga RC, van Leeuwaarde RS, Giles R, Olderode-Berends MJW and
Links TP: The incidence of consecutive manifestations in von
Hippel-Lindau disease. Fam Cancer. 18:369–376. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Solomon D and Schwartz A: Renal pathology
in von Hippel-Lindau disease. Hum Pathol. 19:1072–1079. 1988.
View Article : Google Scholar : PubMed/NCBI
|
